Oil rises on US, China factory strength

Associated Press |

BEIJING (AP) — Oil prices edged up Wednesday on stronger manufacturing activity in the United States and China, the two biggest oil consumers.

Benchmark U.S. crude for August delivery gained 14 cents to $105.48 per barrel in New York, reversing four days of declines. The contract closed at a 10-month high of $107.26 on June 20.

Brent crude, a benchmark for international oils used by many U.S. refineries, gained 9 cents to $112.38 per barrel in London.

Manufacturing activity in China, the world's biggest oil importer, grew in June, according to separate surveys by HSBC Corp. and a Chinese industry group.

In the United States, manufacturing grew for a 13th successive month, though at a slower pace than in May.

Oil prices have risen in recent weeks on concerns that violence in Iraq, OPEC's second-largest exporter, would cut supplies. They stabilized late last week as the stunning initial advance by insurgents lost momentum.

In other energy futures trading on the Nymex:

—Wholesale gasoline rose a fraction of a penny to $3.04 per gallon.

—Natural gas gained 0.2 cents to $4.447 per 1,000 cubic feet.

—Heating oil held steady at $2.978 a gallon.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Companies

Symbol Name Price Change % Volume
SDSS Suspect Detection Sys Inc 0.00 0.00 0.00 0

Comments

Watchlist

Symbol Last Price Change % Change
AAPL

     
AMZN

     
HD

     
JPM

     
IBM

     
BA

     
WMT

     
DIS

     
XOM

     

Level Headed at World Crypto Con - Steve Beauregard

Bloq.com CRO Steve Beauregard joins Jack Brewer at World Crypto Con.

Emerging Growth

Q BioMed Inc

Q BioMed Inc is a biomedical acceleration and development company. The company is a biomedical acceleration and development company focused on licensing, acquiring and providing strategic resources to life sciences…